Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Phlow
Fierce Biotech
Regeneron, Sanofi receive 1- to 2-month priority review vouchers
The national priority vouchers position companies including Merck KGaA, Regeneron and Sanofi to complete the review process in one to two months.
Nick Paul Taylor
Oct 17, 2025 8:30am
Phlow reaps $36M in series B fundraising to boost CDMO program
Apr 6, 2023 9:35am
Insider trading netted ex-Phlow VP and cousin $1.5M, SEC says
Feb 28, 2023 8:40am
Phlow and nonprofit USP team to open drug development lab
Dec 13, 2022 9:50am
Central Virginia looks to future with $2.5M in seed funding
Oct 7, 2021 10:15am
Selkirk eyes 2022 start at its $90M injectables factory
Jun 8, 2021 9:30am
